Mentari Therapeutics Earnings
NASDAQ: MTRIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.70-0.545 (-3.57%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Feb 10, 2027
Revenue estimate
$0
Mentari Therapeutics earnings summary
Mentari Therapeutics is scheduled to report earnings on Feb 10, 2027 on revenue of $0. In its most recent report on Nov 2, 2026 (Sep/2026), MTRI posted EPS of $-0.36.
Summary generated from market data by MetaCap's automated system. Methodology
MTRI earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Nov 2, 2026 | — | $-0.36 | — | +19.5% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.